Project Grant HT9425261E078
Award Date 4/15/26
Completion Date 4/14/30
Dollars Obligated $7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
- Federal Grant Award Summary The Leland Stanford Junior University received a $832,270 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports "High-Throughput In Vivo Lung Cancer Pharmacogenomics," a three-year research initiative conducted at Stanford's California campus. This project advances biomedical research aimed at transforming...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $4.23 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025, through May 31, 2029. This award supports research aimed at advancing cure rates for infantile acute lymphoblastic leukemia (ALL), a pediatric cancer condition. The project has received human use approval and the payment restriction clause has been removed, enabling...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $3,128,801 under the Military Medical Research and Development program (CFDA 12.420) to develop a blood test for measuring sleep deprivation and circadian time. The award, effective June 1, 2025, through May 31, 2028, supports advanced biomedical research directed at transforming healthcare for military service members and the broader public. This research initiative...
- This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
- This $370,866 Formula Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by The Leland Stanford Junior University, a prominent private research university. The grant will fund a 1-year project to uncover synthetically lethal genes that could be targeted in lung cancer in the presence of protein folding stress, with the goal of transforming healthcare for military service members...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,795,499 project grant to The Leland Stanford Junior University, doing business as Stanford University, to conduct an evaluation of clinical responders with advanced triple-negative breast cancer from the KEYNOTE-890 study. The purpose of this 4-year project is to validate a published CXCR3 gene signature that may help identify patients likely to respond to certain cancer...
- The Leland Stanford Junior University was awarded a $4.72 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from March 2021 through March 2025 relating the interplay of tumor function and host response to clinical outcome in triple negative breast cancer. Through this award, Stanford University researchers will investigate medical solutions for breast cancer on the battlefield and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $1,054,071 under the Military Medical Research and Development program (CFDA 12.420) to develop novel inhibitors of NEMO-like kinase for the treatment of Diamond Blackfan Anemia. The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research aimed at identifying and developing therapeutic interventions for this rare blood...
- This $469,381.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Leland Stanford Junior University (Stanford University) to engineer cytotoxic lymphocytes to infiltrate ovarian cancer tumors via metabolite-sensing receptors. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing medical solutions for critical health...